Innovative Financing

Innovative financing mechanisms provide a means of increasing, diversifying and complementing financial support to the Global Fund provided through pledging conferences. The Innovative Financing Team works on building new partnerships to raise additional resources from nontraditional sources.

The Debt2Health mechanism is an opportunity for partnerships between creditors and debtors in the joint pursuit of better health and improved quality of life for the people hardest hit by AIDS, tuberculosis and malaria. While debt swaps are known development financing instruments, the innovative feature of Debt2Health is that creditors agree to relinquish interest payments on a country’s debt on condition that the recipient country invests the freed-up resources in public health using the Global Fund system.

UNITAID is an international drug purchase facility to provide funding for the treatment of the three diseases in developing countries. Access to quality drugs remains a major problem for many patients in many Global Fund partner countries. UNITAID and the Global Fund collaborate in a number of partnerships to increase the affordability of effective treatment where it is most needed.

The Dow Jones Global Fund 50 Index ^SM is the flagship of a new index series that will track companies which support the mission of the Global Fund.. The index has been licensed to db x-trackers, the leading exchange-traded fund (ETF) platform of Deutsche Bank, to serve as a basis for a financial product: the db x-trackers Global Fund Supporters ETF. A portion of the licensing revenues will be given to the Global Fund to finance its programs. This partnership with Dow Jones Indexes provides the financial community with incentives to participate in financing health for development.